Señales en vivo de PLRX | Maximiza tus Ganancias con Getagraph.com

COMPRAR 107812 min ago

@ $16.43

Emitido: 14 feb 2024 @ 15:44

Retorno: -24.81%

Señal anterior: feb 14 - 09:30

Señal anterior: Vender

Retorno: 5.47 %

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 13:36):

Stats
Volumen de hoy	118 779
Volumen promedio	371 556
Capitalización de mercado	744.94M
EPS	$-0.690 ( 2024-03-28 )
Próxima fecha de ganancias	( $-0.770 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.49
ATR14	$0.0290 (0.23%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-23	Lefebvre Eric	Buy	42 900	Common Stock
2024-01-23	Lefebvre Eric	Buy	85 800	Stock Option (Right to Buy)
2024-01-23	Hull Hans	Buy	31 500	Common Stock
2024-01-23	Hull Hans	Buy	63 000	Stock Option (Right to Buy)
2024-01-23	Ouimette Mike	Buy	31 500	Common Stock

INSIDER POWER
67.14
Last 98 transactions
Buy: 2 502 892 \| Sell: 552 083

Volumen Correlación

Largo: -0.37 (neutral)

Corto: -0.47 (neutral)

Signal:(43.183) Neutral

Pliant Therapeutics Inc Correlación

10 Correlaciones Más Positivas
PAIC	0.955
CSII	0.935
ADMS	0.932
RESN	0.927
HSKA	0.921
ZGNX	0.918
OLMA	0.915
NATI	0.914
IPW	0.912
SVAC	0.911

10 Correlaciones Más Negativas
NETE	-0.945
BOCH	-0.932
MMAC	-0.914
RAVN	-0.912
SHSP	-0.879
SBBP	-0.876
CFV	-0.873
AMRB	-0.869
ORMP	-0.869
AZTA	-0.861

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pliant Therapeutics Inc Correlación - Moneda/Commodity

0.56
( weak )

0.67
( moderate )

0.00
( neutral )

0.84
( strong )

0.72
( moderate )

-0.90
( very strong negative )

Pliant Therapeutics Inc Finanzas

Annual	2023
Ingresos:	$1.58M
Beneficio Bruto:	$-261 000 (-16.52 %)
EPS:	$-2.75

FY	2023
Ingresos:	$1.58M
Beneficio Bruto:	$-261 000 (-16.52 %)
EPS:	$-2.75

FY	2022
Ingresos:	$9.69M
Beneficio Bruto:	$6.00M (61.99 %)
EPS:	$-2.89

FY	2021
Ingresos:	$7.57M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.71

Financial Reports:

No articles found.

Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.